Guanglin Wu, Pavithra Dhayakar. "Hibiscus 2 (Trial-in-Progress): A global, Phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of etavopivat in adolescents and adults with sickle cell disease." Blood (2025). https://doi.org/10.1182/blood-2025-2976